US Stock MarketDetailed Quotes

CRDL Cardiol Therapeutics

Watchlist
  • 1.4600
  • +0.1000+7.35%
Close Jan 24 16:00 ET
  • 1.5000
  • +0.0400+2.74%
Post 20:01 ET
119.14MMarket Cap-3.89P/E (TTM)

Cardiol Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
84.70%14.14M
22.59%7.74M
7.95%8.41M
-27.94%29.79M
-11.72%8.03M
-42.09%7.66M
-31.60%6.31M
-20.46%7.79M
6.69%41.34M
-30.56%9.1M
Selling and administrative expenses
104.56%10.39M
77.47%5.03M
38.93%5.08M
-30.45%15.56M
14.71%3.99M
-37.53%5.08M
-41.24%2.84M
-38.42%3.66M
-19.73%22.37M
-63.67%3.48M
-General and administrative expense
104.56%10.39M
77.47%5.03M
38.93%5.08M
-30.45%15.56M
14.71%3.99M
-37.53%5.08M
-41.24%2.84M
-38.42%3.66M
-19.73%22.37M
-63.67%3.48M
Research and development costs
45.56%3.75M
-22.12%2.71M
-19.50%3.32M
-24.99%14.22M
-28.08%4.04M
-49.37%2.58M
-21.05%3.48M
7.28%4.13M
74.44%18.96M
59.25%5.62M
Operating profit
-84.70%-14.14M
-22.59%-7.74M
-7.95%-8.41M
27.94%-29.79M
11.72%-8.03M
42.09%-7.66M
31.60%-6.31M
20.46%-7.79M
-6.91%-41.34M
30.56%-9.1M
Net non-operating interest income expense
-60.84%201.86K
-41.86%307.41K
-30.89%377.29K
64.71%2.04M
-23.32%448.3K
32.41%515.54K
176.32%528.7K
654.97%545.93K
1,067.57%1.24M
2,005.55%584.65K
Non-operating interest income
-60.84%201.86K
-41.86%307.41K
-30.89%377.29K
64.71%2.04M
-23.32%448.3K
32.41%515.54K
176.32%528.7K
654.97%545.93K
1,067.57%1.24M
2,005.55%584.65K
Other net income (expense)
-0.01%1.21M
150.01%843.06K
-863.19%-1.15M
-104.16%-381.25K
-105.68%-56.49K
-75.09%1.21M
-166.07%-1.69M
-80.20%150.87K
32.47%9.17M
-85.39%995.35K
Gain on sale of security
14.11%1.21M
150.01%843.06K
-881.89%-1.18M
-105.90%-530.99K
-105.68%-56.49K
-77.41%1.06M
-166.07%-1.69M
-80.20%150.87K
32.24%9M
-85.35%995.35K
Other non- operating income (expenses)
----
----
--28.22K
-8.94%149.74K
--0
-8.94%149.74K
----
----
46.52%164.44K
--0
Income before tax
-114.64%-12.73M
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
Income tax
Net income
-114.64%-12.73M
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
Net income continuous Operations
-114.64%-12.73M
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
Minority interest income
Net income attributable to the parent company
-114.64%-12.73M
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-114.64%-12.73M
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
Basic earnings per share
-100.00%-0.18
16.67%-0.1
-27.27%-0.14
10.20%-0.44
-9.09%-0.12
30.77%-0.09
-20.00%-0.12
21.43%-0.11
32.88%-0.49
-37.50%-0.11
Diluted earnings per share
-100.00%-0.18
16.67%-0.1
-27.27%-0.14
10.20%-0.44
-9.09%-0.12
30.77%-0.09
-20.00%-0.12
21.43%-0.11
32.88%-0.49
-37.50%-0.11
Dividend per share
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 84.70%14.14M22.59%7.74M7.95%8.41M-27.94%29.79M-11.72%8.03M-42.09%7.66M-31.60%6.31M-20.46%7.79M6.69%41.34M-30.56%9.1M
Selling and administrative expenses 104.56%10.39M77.47%5.03M38.93%5.08M-30.45%15.56M14.71%3.99M-37.53%5.08M-41.24%2.84M-38.42%3.66M-19.73%22.37M-63.67%3.48M
-General and administrative expense 104.56%10.39M77.47%5.03M38.93%5.08M-30.45%15.56M14.71%3.99M-37.53%5.08M-41.24%2.84M-38.42%3.66M-19.73%22.37M-63.67%3.48M
Research and development costs 45.56%3.75M-22.12%2.71M-19.50%3.32M-24.99%14.22M-28.08%4.04M-49.37%2.58M-21.05%3.48M7.28%4.13M74.44%18.96M59.25%5.62M
Operating profit -84.70%-14.14M-22.59%-7.74M-7.95%-8.41M27.94%-29.79M11.72%-8.03M42.09%-7.66M31.60%-6.31M20.46%-7.79M-6.91%-41.34M30.56%-9.1M
Net non-operating interest income expense -60.84%201.86K-41.86%307.41K-30.89%377.29K64.71%2.04M-23.32%448.3K32.41%515.54K176.32%528.7K654.97%545.93K1,067.57%1.24M2,005.55%584.65K
Non-operating interest income -60.84%201.86K-41.86%307.41K-30.89%377.29K64.71%2.04M-23.32%448.3K32.41%515.54K176.32%528.7K654.97%545.93K1,067.57%1.24M2,005.55%584.65K
Other net income (expense) -0.01%1.21M150.01%843.06K-863.19%-1.15M-104.16%-381.25K-105.68%-56.49K-75.09%1.21M-166.07%-1.69M-80.20%150.87K32.47%9.17M-85.39%995.35K
Gain on sale of security 14.11%1.21M150.01%843.06K-881.89%-1.18M-105.90%-530.99K-105.68%-56.49K-77.41%1.06M-166.07%-1.69M-80.20%150.87K32.24%9M-85.35%995.35K
Other non- operating income (expenses) ----------28.22K-8.94%149.74K--0-8.94%149.74K--------46.52%164.44K--0
Income before tax -114.64%-12.73M11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M
Income tax
Net income -114.64%-12.73M11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M
Net income continuous Operations -114.64%-12.73M11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M
Minority interest income
Net income attributable to the parent company -114.64%-12.73M11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -114.64%-12.73M11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M
Basic earnings per share -100.00%-0.1816.67%-0.1-27.27%-0.1410.20%-0.44-9.09%-0.1230.77%-0.09-20.00%-0.1221.43%-0.1132.88%-0.49-37.50%-0.11
Diluted earnings per share -100.00%-0.1816.67%-0.1-27.27%-0.1410.20%-0.44-9.09%-0.1230.77%-0.09-20.00%-0.1221.43%-0.1132.88%-0.49-37.50%-0.11
Dividend per share
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Meta Platforms
META
+1.73%
Alphabet-C
GOOG
+1.16%
Alphabet-A
GOOGL
+1.13%
Vale SA
VALE
+1.01%
Coinbase
COIN
+0.67%

Unlock the Full List